Liberalism, lack and living the dream : re-considering youth, consumer sovereignty and the attractions of night-time leisure in Magaluf

Much of the academic literature on alcohol-based leisure focuses on the pleasures of hedonism and youthful cultural exploration in environments free from the prescriptions, pressures and routines of everyday life. In this article – in which we present data from our ongoing ethnographic research exploring the experiences and attitudes of young British tourists in the Spanish resort of Magaluf on the island of Majorca – we argue that the standard liberal social-scientific image of youth leisure is naive and misrepresents its variegated reality. Our research indicates that many young British tourists gain little contentment from their holiday in the sun. Rather than embarking on a leisure experience composed of boundless freedom, choice, indulgence, excess and that is indicative of personal consumer sovereignty, many of our interviewees could identify the regimented and commodified nature of alcohol-based tourism. Rather than satisfaction, they felt an imprecise dissatisfaction. Drawing upon elements of psychoanalytic theory, we argue that underneath our interviewees’ accounts of drunkenness and promiscuity lies an obdurate but imprecise sense of lack. Yet, it is precisely this absence which only recharges their motivation to do more of the same the year after in similar destinations, thus confirming the presence, power and domination of consumer sovereignty

Hagamos visible la dirección de personas.

[EN] “Let’s make people management visible” is an innovation project that was run in all 2nd year groups for the Managing People courses, within the Social Science Faculty. The project involved all the teachers who taught this course, and was organized around cooperative learning. The objective of this project was the students to understand and learn, in a playful way, the basics of People Management. To this end, students organized in teams, created a video documentary and a business case that should reflect one of the following areas of knowledge contained in the syllabus: job design, recruitment and selection, training, performance appraisal and motivation. To prepare the content for the video, students used bibliographic and audiovisual resources and they worked with the role‐ playing technique. After the videos were finished, students shared their acquired knowledge by putting in common their work and by solving the business cases developed by the other groups. The competencies developed were: teamwork, empathy, tolerance, decision making, responsibility and creativity. Thirty videos were submitted to the contest and published in the V Seminar on Human Resources, "Talentum."[ES] "Hagamos visible la dirección de personas" es un proyecto de innovación que fue llevado a la práctica en todos los grupos de 2 º año de grado de los cursos de Dirección de Personas, en la Facultad de Ciencias Sociales. El proyecto involucró a todos los profesores que imparten este curso, y se organizó en torno al aprendizaje cooperativo. El objetivo de este proyecto fue que los estudiantes entendieran y aprendieran, de una manera lúdica, os fundamentos de la Gestión de Personas. Con este fin, los estudiantes organizados en equipos, crearon un video documental y un caso que debían reflejar una de las siguientes áreas de conocimiento contenida en el plan de estudios: diseño de puestos de trabajo, reclutamiento y selección, formación, evaluación del desempeño y motivación. Para preparar el contenido del video, los estudiantes utilizaron recursos bibliográficos y audiovisuales y se trabajó con la técnica de rol. Una vez que los videos se terminaron, los estudiantes compartieron sus conocimientos adquiridos mediante la puesta en común de su trabajo y resolvieron los casos desarrollados por los otros grupos. Las competencias desarrolladas fueron: el trabajo en equipo, la empatía, la tolerancia, la toma de decisiones, la responsabilidad y la creatividad. Treinta videos fueron presentados a concurso y publicado en el V Seminario de Recursos Humanos "Talentum"[FR] “Rendons le Management de Personnes Évident”, c’est une activité d’innovation qui a eu lieu dans tous les groupes de 2eme année dans le cadre de la matieré “Direction du Personnel”, dans la Faculté de Sciences Sociales. Le projet a eté encadré par tous les professeurs qui enseignent cette matiére. En prennant comme base l’apprentissage coopératif, l’objectif a etait de rendré les etudiants capable de comprendre et apprendre, d’une façon ludique, les principes basics du Management de Personnes. À cet effet, les étudiants organisés en équipes, ont créé un documentaire visuel et un “cas d'affaires” qui devaient refléter un des domaines de connaissance contenus dans le programme: système de travail, recrutement, formation, évaluation du travail et motivation. Pour réaliserur la vidéo, les étudiants ont consulté des bibliographies specialisées, ainsi que des sources audiovisuelles. Ils ont travillé aussi avec la technique du role‐playing.Une fois les videos terminées, les étudiants ont partagé leur connaissance acquise en mettant en commun leur travail et leurs solutions aux différents cas d'affaires développés dans lesdifférents groupes. Les compétences développées ont eté: travail d'équipe, empathie, tolérance, prise de décision, responsabilité et créativité. Trente des videos ont été présentées au concours et édités dans le V Conference de Ressources Humaines, «Talentum. »Moldes Farelo, R.; García-Salmones, L.; Gómez Sota, F.; Cordero Verdugo, RR.; Rodriguez Polo, B. (2011). Let's make people management visible. REDU. Revista de Docencia Universitaria. 8(2):95-116. https://doi.org/10.4995/redu.2010.6197OJS9511682BENITO, A y CRUZ, A. (2007), Nuevas claves para la docencia universitaria en el Espacio Europeo de Educación Superior, Madrid, Ed. Narcea.DE MIGUEL, DÍAZ, M. (COORD.); (2006), Metodología de enseñanza y aprendizaje para el desarrollo de competencias. Orientaciones para el profesorado universitario ante el Espacio Europeo de Educación Superior, Madrid, Ed. Alianza.DÍAZ AGUADO, M. (2003), Educación intercultural y aprendizaje cooperativo, Madrid, Ed. Pirámide.JOHNSON, D., JOHNSON, R., SMITH, K. (1997) El aprendizaje cooperativo regresa a la Universidad: ¿qué evidencia existe de qué funciona?, Universidad de Minnesota.MARTÍNEZ, F. (ED.); (2003) Redes de comunicación en la enseñanza. Las nuevas perspectivas del trabajo cooperativo, Barcelona, Paidós.MERCER, N. (2001), Palabras y mentes. Cómo usamos el lenguaje para pensar juntos, Barcelona, Paidós.MONEREO, C., DURÁN, D. (2003) Entramados. Métodos de aprendizaje cooperativo y colaborativo, Barcelona, EdebéPUTNAM, J. (1997) Cooperative learning in diverse classrooms. Nueva York: Prentice‐Hall.SLAVIN, R. (1995) Cooperative learning, Massachusetts, Alyn & Bacon.THOUSAND,.; NEVIN, V.; VILA, R.; (1994), An overview of cooperative learning. Creativity and collaborative learning. A practical guide to empowering students and teachers, Baltimore, Paul H. Brookes

Comunicación docente

En este capítulo de libro abordamos la importancia de la comunicación para la profesión docente en el contexto educativo. Se dan pautas generales sobre cómo comunicar mejor y eficazmente tanto abordando la comunicación verbal como la no verbal. Dentro del apartado titulado: "El profesorado y la interculturalidad en el aula" a través de un ejemplo práctico como es el diálogo entre un profesor y un alumno se dan pautas para ser un/a profesional intercultural.2020-2

Delincuencia y seguridad de las apps afectivo-sexuales, con base en la etnografía realizada en el Proyecto Enrolla2

Los Proyectos “Enrolla2 Generación X Percepciones de Seguridad y Actitudes de Riesgo en individuos pertenecientes a la Generación X vinculadas al uso de aplicaciones informáticas afectivo-sexuales (CIPI/20/091)” y “La gestión del deseo en tiempos del COVID (CIPI/20/159)” tenían como respectivos objetivos, estudiar la percepción de la seguridad, su incidencia en el nivel de victimización y los riesgos para la salud de los individuos en las aplicaciones afectivo-sexuales; y conocer las motivaciones que han llevado a los mismos a usar apps afectivo-sexuales durante el confinamiento. Se observaron diferentes niveles de seguridad en las apps, dependiendo del tratamiento de los datos de los usuarios, la existencia de actitudes de hostigamiento y la emergencia de un mercado de droga digital. Jurídicamente, se presume necesario mejorar la protección de los usuarios, potenciales víctimas de delitos -singularmente identificados, especialmente llamativo en el caso de la revelación de la intimidad- y, asimismo, incentivar la cultura de la prevención o compliance con respecto a las entidades propietarias de dichas plataformas. Precisamente por ello, en esta ocasión[1] se hará especial hincapié en este último aspecto, la responsabilidad de la persona jurídica, la Ética Empresarial, los Compliance Program y la Inteligencia Artificial.   [1] Algunas partes de este trabajo ya han sido previamente publicadas

Theory for the FCC-ee : Report on the 11th FCC-ee Workshop

The Future Circular Collider (FCC) at CERN, a proposed 100-km circular facility with several colliders in succession, culminates with a 100 TeV proton-proton collider. It offers a vast new domain of exploration in particle physics, with orders of magnitude advances in terms of Precision, Sensitivity and Energy. The implementation plan foresees, as a first step, an Electroweak Factory electron-positron collider. This high luminosity facility, operating between 90 and 365 GeV centre-of-mass energy, will study the heavy particles of the Standard Model, Z, W, Higgs, and top with unprecedented accuracy. The Electroweak Factory $e^+e^-$ collider constitutes a real challenge to the theory and to precision calculations, triggering the need for the development of new mathematical methods and software tools. A first workshop in 2018 had focused on the first FCC-ee stage, the Tera-Z, and confronted the theoretical status of precision Standard Model calculations on the Z-boson resonance to the experimental demands. The second workshop in January 2019, which is reported here, extended the scope to the next stages, with the production of W-bosons (FCC-ee-W), the Higgs boson (FCC-ee-H) and top quarks (FCC-ee-tt). In particular, the theoretical precision in the determination of the crucial input parameters, alpha_QED, alpha_QCD, M_W, m_t at the level of FCC-ee requirements is thoroughly discussed. The requirements on Standard Model theory calculations were spelled out, so as to meet the demanding accuracy of the FCC-ee experimental potential. The discussion of innovative methods and tools for multi-loop calculations was deepened. Furthermore, phenomenological analyses beyond the Standard Model were discussed, in particular the effective theory approaches. The reports of 2018 and 2019 serve as white papers of the workshop results and subsequent developments

En la ciudad del positivismo perdido: lecciones aprendidas para una criminología urbana

En el presente artículo realizamos un acercamiento a cómo el postpositivismo, la liquidez y el capitalismo han afectado mediante su corriente neoliberal a las escuelas de pensamiento de las Ciencias Sociales y su método de investigación. Realizando una aproximación en base a tres realidades distintas como es el fenómeno de los refugiados políticos, los homeless y el ciberporno, podremos observar las limitaciones actuales en materia de investigación para con algunas fenomenologías y realizaremos una propuesta de abordaje basado en una Criminología más urbana y los mixed methods

VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY

Introduction: VEN is a potent, selective BCL-2 inhibitor with clinical activity in R/R NHL pts. Preclinical data suggest synergy between VEN and both B and R; together BR is one of the most commonly used regimens in NHL. Final results of a dose finding study of VEN + BR (NCT01594229) are reported. Methods: This was a Phase 1 dose finding study of VEN + BR in pts ≥18 years with R/R NHL and ECOG PS of 0-1. Diffuse large B-cell lymphoma (DLBCL) pts who progressed during/within 2 months (mo) of most recent therapy, and pts with mantle cell lymphoma, were excluded. Dose escalation followed a 3 + 3 design. Oral VEN (50-1200 mg) was given for 3, 7 or 28 consecutive days (d) of each 28d cycle. BR regimen was 6 cycles: B (90 mg/m2 , IV, 2d/cycle) and R (375 mg/m2 IV, 1d/cycle). After completing VEN + BR, pts could continue VEN alone for ≤2 years after the date of last subject enrolled (maintenance) in the absence of progression and/or unacceptable toxicity. Primary endpoints included safety, pharmacokinetics, maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D); secondary endpoint was preliminary efficacy. Adverse events (AE) were graded per NCI CTCAE v4.0 and efficacy per 2007 IWG criteria. Data cut-off was Feb 15, 2017. Results: Between Jun 2012 and Oct 2015 60 pts were enrolled. Median age was 62 (range, 29-90) years; 53% (n = 32) had follicular lymphoma (FL), 37% (n = 22) had DLBCL and 10% (n = 6) had marginal zone lymphoma (MZL). Pts had a median of 3 (1-8) prior therapies. Median time on study was 7.7 (0.13-51.3) mo.Overall, 98% pts had an AE; most frequent (any grade) were nausea, neutropenia (68% each), diarrhea (55%) and thrombocytopenia (52%). Most common Grade 3/4 AEs were neutropenia (60%), and lymphopenia (38%). 24 pts reported serious AEs, with febrile neutropenia (FN) and AEs related to disease progression (8%) the most frequent. 29 pts discontinued the study (PD, n = 16; withdrawn consent, n = 4; AEs, n = 3; other, n = 6); 5 pts died from either disease progression (n = 4) or respiratory failure (n = 1). After early incidents of FN the protocol was revised to incorporate use of G-CSF. MTD was not reached; RP2D for VEN + BR was declared 800 mg continuously. VEN exposure with and without BR was comparable. The table presents efficacy data. Conclusions: VEN + BR demonstrated tolerable safety profile at up to 1200 mg continuously, and significant clinical activity; 800 mg VEN continuously is being used in the randomized CONTRALTO study. In pts with indolent lymphoma who received maintenance VEN, durable responses were observed

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study

Background: Venetoclax is a selective, potent inhibitor of the anti-apoptotic B-cell leukemia/lymphoma-2 protein approved for treatment of chronic lymphocytic leukemia. We conducted a dose-finding study of venetoclax in combination with bendamustine-rituximab (BR) in patients with relapsed/refractory non-Hodgkin\u27s lymphoma (NHL). Patients and methods: BR was given for six cycles at standard doses. Intermittent and continuous oral venetoclax administration was explored at 50-1200 mg daily doses. Co-primary objectives included safety, pharmacokinetics (PKs), maximum-tolerated dose (MTD), and recommended phase II dose (RP2D); secondary objective was preliminary efficacy. Results: Sixty patients were enrolled: 32 with follicular lymphoma, 22 with diffuse large B-cell lymphoma, and 6 with marginal zone lymphoma. Nausea (70%), neutropenia (68%), diarrhea (55%), and thrombocytopenia (52%) were the most frequent adverse events (AEs). Most common grade 3/4 AEs were neutropenia (60%) and lymphopenia (38%). Serious AEs were reported in 24 patients; the most frequent were febrile neutropenia and disease progression (8% each). Five patients died from either disease progression (n = 4) or respiratory failure (n = 1). MTD was not reached; RP2D for venetoclax-BR combination was established as 800 mg daily continuously. Venetoclax PK exposure with and without BR was comparable. For all patients, overall response rate was 65%. Median duration of overall response, overall survival, and progression-free survival was 38.3 months [95% confidence interval (CI) 10.4-NR], not yet reached, and 10.7 months (95% CI 4.3-21.0), respectively. Conclusions: This study established the safety profile of venetoclax in combination with BR, and results demonstrated tolerability and preliminary efficacy of the combination. Additional follow-up is needed to better determine the future role of BR plus venetoclax in the treatment of relapsed/refractory B-cell NHL. Trial registered: Clinicaltrials.gov, NCT01594229